← Leaderboards
Ingo K Mellinghoff
Sloan-Kettering Inst Can Research
$6,692,369
Attributed
$6,692,369
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $601.1K · FY2012–25$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,692,369 · 2
By mechanism
R35$4,729,652 · 1
R01$1,962,717 · 1
Top collaborators
No co-investigators on record.
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Andrew Michael Intlekofer$5,190,407
- Sriram Venneti$4,778,176
- Craig B Thompson$56,520,903
- Kayvan R Keshari$12,246,491
- Michael Kharas$18,485,709
Others in their field
Top investigators on “Maintenance”
- Ethan Schreier · Associated Universities, Inc.$592,191,360
- David Heimbrook · Leidos Biomedical Research, Inc.$543,912,903
- Jeffrey P Krischer · University Of South Florida$462,749,776
- William S Smith · Association Of Universities For Research In Astronomy, Inc.$308,084,240
- Albert Lazzarini · California Institute Of Technology$248,930,000
- David H Reitze · University Of Florida$248,930,000
Research focus
MaintenanceMutantTumorMalignant NeoplasmsAdultMolecularGliomaMutationBaseInhibitor/AntagonistIsocitrate DehydrogenaseBiopsyCentral Nervous System LymphomaChemotherapyAgammaglobulinaemia Tyrosine KinaseMolecular ProfilingImpaired CognitionGenetic StudyGlioblastomaCombined Modality TherapyBrain NeoplasmsEpidermal Growth Factor ReceptorEvaluationDrug Resistance
Grant awards (13)
Molecular Mechanisms of Drug Resistance in Primary Brain Tumors$540,855
R35 · FY2025 · NS · contact PI
Molecular Mechanisms of Drug Resistance in Primary Brain Tumors$582,922
R35 · FY2024 · NS · contact PI
Molecular Mechanisms of Drug Resistance in Primary Brain Tumors$600,950
R35 · FY2023 · NS · contact PI
Molecular Mechanisms of Drug Resistance in Primary Brain Tumors$600,950
R35 · FY2022 · NS · contact PI
Molecular Mechanisms of Drug Resistance in Primary Brain Tumors$600,950
R35 · FY2021 · NS · contact PI
Molecular Mechanisms of Drug Resistance in Primary Brain Tumors$600,950
R35 · FY2020 · NS · contact PI
Molecular Mechanisms of Drug Resistance in Primary Brain Tumors$600,950
R35 · FY2019 · NS · contact PI
Molecular Mechanisms of Drug Resistance in Primary Brain Tumors$601,125
R35 · FY2018 · NS · contact PI
Molecular Mechanisms of IDH1-mediated Gliomagenesis$391,992
R01 · FY2016 · NS · contact PI
Molecular Mechanisms of IDH1-mediated Gliomagenesis$392,228
R01 · FY2015 · NS · contact PI
Molecular Mechanisms of IDH1-mediated Gliomagenesis$388,532
R01 · FY2014 · NS · contact PI
Molecular Mechanisms of IDH1-mediated Gliomagenesis$378,936
R01 · FY2013 · NS · contact PI
Molecular Mechanisms of IDH1-mediated Gliomagenesis$411,029
R01 · FY2012 · NS · contact PI